Discover
TIL
Instil Bio, Inc.
7.49
1 x 7.47
2 x 7.50
bid
ask
+
0.08
1.08%
undefined @ 04:00 PM
7.49 +0.00 (0.00%)
| Ytd | -31.91% | |
| 1y | -73.58% |
7.37
day range
7.50
5.67
52 week range
33.83
| Open | 7.47 | Prev Close | 7.41 | Low | 7.37 | High | 7.50 | Mkt Cap | 50.80M |
| Vol | 6.51K | Avg Vol | 18.38K | EPS | -7.08 | P/E | -1.06 | Forward P/E | -1.80 |
| Beta | 1.74 | Short Ratio | 2.29 | Inst. Own | 80.70% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 03-04 | 50-d Avg | 7.60 | 200-d Avg | 9.29 | 1yr Est | 100.33 |
| Income Statement | |||
| Operating Expenses | 5.39M | ||
| Research and Development Expense | 669.00K | ||
| Selling, General and Administrative Expense | 5.35M | ||
| Operating Income | -5.39M | ||
| Interest Expense | 1.55M | ||
| Net Income | -4.20M | ||
| Net Income Common Stock | -4.20M | ||
| Net Income Common Stock (USD) | -4.20M | ||
| Consolidated Income | -4.20M | ||
| Earnings per Basic Share | -0.62 | ||
| Earnings per Basic Share (USD) | -0.62 | ||
| Earnings per Diluted Share | -0.62 | ||
| Earning Before Interest & Taxes (EBIT) | -2.65M | ||
| Earning Before Interest & Taxes (USD) | -2.65M | ||
| Weighted Average Shares | 6.78M | ||
| Weighted Average Shares Diluted | 6.78M | ||
| Balance Sheet | |||
| Cash and Equivalents | 5.15M | ||
| Cash and Equivalents (USD) | 5.15M | ||
| Investments | 69.55M | ||
| Investments Current | 69.55M | ||
| Current Assets | 188.30M | ||
| Property, Plant & Equipment Net | 172.00K | ||
| Total Assets | 200.43M | ||
| Total Debt | 85.00M | ||
| Current Liabilities | 4.72M | ||
| Debt Non-Current | 85.00M | ||
| Total Liabilities | 89.73M | ||
| Accumulated Retained Earnings (Deficit) | -730.69M | ||
| Accumulated Other Comprehensive Income | -532.00K | ||
| Shareholders Equity | 110.70M | ||
| Shareholders Equity (USD) | 110.70M | ||
| Assets Non-Current | 12.13M | ||
| Total Debt (USD) | 85.00M | ||
| Liabilities Non-Current | 85.01M | ||
| Trade and Non-Trade Payables | 793.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 83.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.65M | ||
| Net Cash Flow from Investing | -317.00K | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -317.00K | ||
| Net Cash Flow from Operations | -1.34M | ||
| Effect of Exchange Rate Changes on Cash | -5.00K | ||
| Share Based Compensation | 985.00K | ||